Green tea catechins are potent sensitizers of ryanodine receptor type 1 (RyR1).
Catechins, polyphenols extracted from green tea leaves, have a broad range of biological activities although the specific molecular mechanisms responsible are not known. At the high experimental concentrations typically used polyphenols bind to membrane phospholipid and also are easily auto-oxidized to generate superoxide anion and semiquinones, and can adduct to protein thiols. We report that the type 1 ryanodine receptor (RyR1) is a molecular target that responds to nanomolar (-)-epigallocatechin-3-gallate (EGCG) and (-)-epicatechin-3-gallate (ECG). Single channel analyses demonstrate EGCG (5-10nM) increases channel open probability (Po) twofold, by lengthening open dwell time. The degree of channel activation is concentration-dependent and is rapidly and fully reversible. Four related catechins, EGCG, ECG, EGC ((-)-epigallocatechin) and EC ((-)-epicatechin) showed a rank order of activity toward RyR1 (EGCG>ECG>>EGC>>>EC). EGCG and ECG enhance the sensitivity of RyR1 to activation by < or =100microM cytoplasmic Ca(2+) without altering inhibitory potency by >100microM Ca(2+). EGCG as high as 10microM in the extracellular medium potentiated Ca(2+) transient amplitudes evoked by electrical stimuli applied to intact myotubes and adult FDB fibers, without eliciting spontaneous Ca(2+) release or slowing Ca(2+) transient recovery. The results identify RyR1 as a sensitive target for the major tea catechins EGCG and ECG, and this interaction is likely to contribute to their observed biological activities.
Feng
Wei
W
Department of Molecular Biosciences, University of California, Davis, 95616, United States of America. fengwei@ucdavis.edu
Cherednichenko
Gennady
G
Ward
Chris W
CW
Padilla
Isela T
IT
Cabrales
Elaine
E
Lopez
José R
JR
Eltit
José M
JM
Allen
Paul D
PD
Pessah
Isaac N
IN
D000200:Action Potentials; D000328:Adult; D016588:Anticarcinogenic Agents; D000975:Antioxidants / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D006801:Humans; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D010936:Plant Extracts / Q000737:chemistry*; D019837:Ryanodine Receptor Calcium Release Channel / Q000187:drug effects* / Q000378:metabolism; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology; D013329:Structure-Activity Relationship; D009435:Synaptic Transmission / Q000187:drug effects; D013662:Tea / Q000737:chemistry
D016588:Anticarcinogenic Agents; D000975:Antioxidants; D010936:Plant Extracts; D019837:Ryanodine Receptor Calcium Release Channel; D013662:Tea; D002392:Catechin; C062669:epicatechin gallate; C045651:epigallocatechin gallate; C057580:gallocatechol
Biochim Biophys Acta. 1993 Apr 8;1147(1):132-6
8466924
Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1704-14
16356131
Synapse. 2007 Nov;61(11):889-902
17663453
Prev Med. 1992 May;21(3):334-50
1614995
Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1025-32
12376503
Eur J Pharmacol. 2006 Dec 15;552(1-3):123-30
17059816
Biofactors. 2000;13(1-4):147-51
11237174
Mol Pharmacol. 1999 May;55(5):821-31
10220560
J Neurosci. 2001 Jun 1;21(11):3860-70
11356874
Mol Nutr Food Res. 2008 Apr;52(4):465-71
18324707
Mol Pharmacol. 2006 Jul;70(1):259-66
16601083
Biophys J. 1983 Jul;43(1):1-4
6603872
Chem Res Toxicol. 2009 Jan;22(1):201-7
18954145
Antioxid Redox Signal. 2008 Mar;10(3):475-510
18154485
J Appl Physiol (1985). 2008 Sep;105(3):923-32
18583385
Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):260-7
14647974
Xenobiotica. 2001 Dec;31(12):891-901
11780763
Mol Nutr Food Res. 2006 Feb;50(2):229-34
16470637
Biochim Biophys Acta. 2002 Jan 15;1569(1-3):35-44
11853955
Biochem Biophys Res Commun. 1985 Apr 16;128(1):449-56
3985981
J Biol Chem. 1988 Dec 15;263(35):18750-8
3198599
Am J Physiol Cell Physiol. 2007 May;292(5):C1591-8
17182726
J Biol Chem. 2004 Aug 13;279(33):34514-20
15197184
Naunyn Schmiedebergs Arch Pharmacol. 2009 Jun;379(6):551-64
19221718
Proc Soc Exp Biol Med. 1999 Apr;220(4):262-6
10202400
Clin Cancer Res. 2005 Jun 15;11(12):4627-33
15958649
Free Radic Biol Med. 1999 Oct;27(7-8):855-63
10515590
Eur J Biochem. 2004 Sep;271(17):3470-80
15317582
Free Radic Biol Med. 2008 Nov 15;45(10):1384-94
18771724
Free Radic Biol Med. 2003 Mar 15;34(6):648-62
12633742
Mol Pharmacol. 1991 May;39(5):679-89
1851961
FASEB J. 2003 Aug;17(11):1517-9
12824280
Physiol Rev. 2009 Oct;89(4):1153-76
19789379
Biophys J. 2007 May 1;92(9):3178-94
17293394
Biophys J. 2009 Feb;96(3):1026-35
19186140
Mol Pharmacol. 1990 Apr;37(4):503-14
2157959
J Physiol. 1987 Feb;383:269-83
3498820
J Agric Food Chem. 2003 Sep 10;51(19):5798-802
12952436
J Physiol. 2005 Apr 15;564(Pt 2):451-64
15731192
Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15793-8
15505226
J Biol Chem. 2000 Nov 17;275(46):35902-7
10998414
Mol Pharmacol. 2008 Apr;73(4):1203-12
18171728
J Pharmacol Exp Ther. 1991 Mar;256(3):938-46
1848635
J Biol Chem. 2007 Mar 23;282(12):8667-77
17237236
Cell Calcium. 2008 Mar;43(3):307-14
17707505
Histochem Cell Biol. 2008 Apr;129(4):489-501
18264714
J Biol Chem. 1999 Nov 12;274(46):32603-12
10551814